O'Keefe Stevens Advisory’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.04M Buy
28,975
+540
+2% +$18.2K 0.21% 44
2026
Q1
$1.02M Buy
28,435
+1,055
+4% +$27.3K 0.25% 45
2025
Q4
$544K Sell
27,380
-36
-0.1% -$693 0.14% 49
2025
Q3
$500K Buy
27,416
+599
+2% +$9.85K 0.14% 49
2025
Q2
$423K Buy
26,817
+2,903
+12% +$36.9K 0.12% 53
2025
Q1
$303K Buy
23,914
+4,495
+23% +$70.6K 0.1% 54
2024
Q4
$428K Buy
+19,419
New +$408K 0.13% 52

Other funds holding CLMT

O'Keefe Stevens Advisory's CLMT Position: Q2 2026 in Review

O'Keefe Stevens Advisory increased its Calumet Specialty Products (CLMT) stake by 1.9% in Q2 2026, buying an estimated $18.2K and bringing the position to 28,975 shares worth $1.04M. The position accounts for 0.21% of the portfolio, ranked #44.

O'Keefe Stevens Advisory first reported a position in CLMT in Q4 2024 and has held it in 7 quarters since. 21 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

  • O'Keefe Stevens Advisory held 28,975 shares of Calumet Specialty Products worth $1.04M as of Q2 2026.
  • O'Keefe Stevens Advisory bought 540 Calumet Specialty Products shares in Q2 2026, an estimated $18.2K.
  • Calumet Specialty Products made up 0.21% of O'Keefe Stevens Advisory's portfolio in Q2 2026, its #44 holding.
  • O'Keefe Stevens Advisory first reported a position in Calumet Specialty Products in Q4 2024 and has held it in 7 quarters since.
  • 21 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on O'Keefe Stevens Advisory's 13F filing for Q2 2026, filed 13 Jul 2026.